The Weber-curve pitfall: Effects of a forced introduction on reporting rates and reported adverse reaction profiles

Pharmacy World and Science

Volumn 25, Issue 6, 2003, Pages 260-263

  De Graaf, Linda ^a   Fabius, Mariette A ^a   Diemont, Willem L ^a   Van Puijenbroek, Eugène P ^a  

^a NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

Author keywords

Adverse drug reaction; Omeprazole; Pharmacovigilance; Weber effect

Indexed keywords

LOSEC MUPS; OMEPRAZOLE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BILIARY TRACT DISEASE; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DRUG CAPSULE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DUODENUM ULCER; DYSPEPSIA; ENDOCRINE DISEASE; ERYTHROCYTE DISORDER; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GENITAL SYSTEM DISEASE; HEARING DISORDER; HEART ARRHYTHMIA; HUMAN; INJECTION SITE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM DISEASE; MEDICAL DOCUMENTATION; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NETHERLANDS; NUTRITIONAL DISORDER; PERIPHERAL NEUROPATHY; REFLUX ESOPHAGITIS; RESPIRATORY TRACT DISEASE; SENSORY DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; TABLET; THROMBOCYTE DISORDER; URINARY TRACT DISEASE; VASCULAR DISEASE; VESTIBULAR DISORDER; VISUAL DISORDER;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0345095321     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000006518.22231.ea     Document Type: Article

References (8)

1. College voor zorgverzekeringen. Farmacotherapeutisch Kompas 2000/2001, Utrecht, The Netherlands: Roto Smeets 2000.
2. Nefarma. Repertorium 1998/1999. The Hague, The Netherlands: SDU Service-centrum Uitgeverijen 1998.
3. Katelaris PH, Phelps G. A randomised controlled comparison of omeprazole capsules and multiple unit pellet system tablets for healing ulcerative oesophagitis. Aust Gastroenterology Week 1999; 14: A113 (Suppl) (Abstract).
4. Anderberg EK. Bioequivalence between omeprazole MUPS® tablets and omeprazole capsules. Gastroenterology 1998; 114(4): A56 (Abstract).
5. Broekmans AW, Lekkerkerker JFF, Koning de GHP, Vree PH. Nieuwe regels voor het melden van bijwerkingen in Nederland na 1995. [New rules for the reporting of adverse drug reactions in the Netherlands.] Ned Tijdschr Geneeskd 1996; 140(22); 1166-7.
6. Weber JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In: Advances in Inflammation Research, Volume 6. New York: Raven Press, 1984.
7. Anonymous. WHO Adverse Reaction Dictionary. Uppsala, Sweden: WHO Collaborating Centre for International Drug Monitoring, 1995.
8. De Craen AJM, Roos PJ, De Vries AL, Kleijnen J. Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 1996; 313: 1624-6.